Skip to main content
News Icon

News categories: Honors & Funding

Collaborative research center being renewed

German Research Foundation funds CRC "Synaptic Micronetworks in Health and Disease" for another four years

The mammalian brain is extraordinarily complex - it is estimated to consist of around 100 billion nerve cells. Each of these cells is linked via synapses to tens of thousands of other brain cells. How do the elements of such a complex network work together to produce behavior? How do the networks change as a result of disease? For eight years, scientists have been investigating these and other questions in the Collaborative Research Center (CRC) 1089 "Synaptic Micronetworks in Health and Disease" at the University of Bonn. With great success: The German Research Foundation (DFG) is funding the interdisciplinary network for another four years. The requested funding amount is around 11.1 million euros. Partners are the caesar research center in the Max Planck Society and the German Center for Neurodegenerative Diseases in Bonn. Member of the Cluster of Excellence ImmunoSensation2 Prof. Heinz Beck is spokesperson of the recently renewed CRC.

At the most elementary level, the researchers want to investigate the properties of individual synapses - the contact points between nerve cells. They also want to investigate how these connections between brain cells are affected by diseases in their structure and function. At the next level up, the scientists want to find out how the many tens of thousands of synaptic input signals that arrive at cell processes of the nerve cells, so-called dendrites, are processed. Here, too, the focus is on epilepsy and Alzheimer's disease. At the level of neuronal networks, the researchers are interested in understanding the interplay between different types of nerve cells in the development of normal and pathologically disturbed behavior. To achieve these goals, mathematical and theoretical methods will be increasingly applied in the third funding period.

The researchers in the interdisciplinary CRC 1089 aim to make a significant contribution to a better understanding of how the brain works. However, a particular goal is also to investigate brain dysfunction in two of the most common neurological diseases: Epilepsy and Alzheimer's disease. The speaker of the Collaborative Research Center is the neuroscientist Prof. Dr. Heinz Beck, head of the Institute for Experimental Epileptology and Cognition Research at the University and the University Hospital of Bonn and a member of the ImmunoSensation2 Cluster of Excellence. Vice speaker is the biochemist Prof. Dr. Susanne Schoch McGovern from the Institute of Neuropathology at the University of Bonn.


Contact

Prof. Dr. Heinz Beck

Institute for Experimental Epileptology and Cognitive Research

University of Bonn

University Hospital Bonn

Phone: +49 228 6885270

Email: Heinz.Beck@ukb.uni-bonn.de

Prof. Dr. Susanne Schoch McGovern

Institute of Neuropathology, University of Bonn

University Hospital Bonn

Phone: +49 228 28719109

Email: susanne.schoch@uni-bonn.de

Related news

Prof. Dr. Elvira Mass (left) and Prof. Dr. Tatjana Tchumatchenko (right)

News categories: Honors & Funding

Hunting for New Angles

New research questions often arise where different methods, mindsets and subject-specific cultures meet, and it is these kinds of encounter that Professor Elvira Mass and Professor Tatjana Tchumatchenko want to make happen in a targeted way in future. The two researchers have been picked as Henriette Herz Scouts by the Alexander von Humboldt Foundation.
View entry
Precise Konsortium

News categories: Publication Honors & Funding

Making Cancer Cells More Predictable: PRECISE Aims to Forecast Therapeutically Actionable Vulnerabilities

Which genes and signaling pathways does a cancer cell require to survive? And which of these could serve as therapeutic targets? The pan-European initiative PRECISE aims to identify such vulnerabilities not only through labor-intensive laboratory experiments but also by predicting them using computational models. The UKB and the University of Bonn, represented by Prof. Dr. Maximilian Billmann and Prof. Dr. Jonathan Schmid-Burgk, are among the founding partners of the consortium. The scientific vision of the initiative has now been published in a commentary in Nature Genetics.
View entry
Prof. Dr. Jörg Wenzel

News categories: Honors & Funding

Jörg Wenzel elected chair of EADV Task Force on Cutaneous Lupus Erythematosus (CLE)

The European Academy of Dermatology and Venereology (EADV) has establishment a new Task Force on Cutaneous Lupus Erythematosus (CLE), led by ImmunoSensation³ member Jörg Wenzel. CLE, as autoimmune disease of the skin, is a prime example of chronic inflammatory dysregulation, leading to a severe disease burden. The treatment of cutaneous lupus continues to face unresolved clinical challenges. The CLE Task Force is set up to push the boundaries of clinical care, update guidelines, and advance collaborative research across Europe.
EADV Task Forces

Back to the news overview